These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8590250)

  • 41. The antihypertensive property of NIP-121, a novel potassium channel opener in rats.
    Masuda Y; Arakawa C; Yokoyama T; Shigenobu K; Tanaka S
    J Cardiovasc Pharmacol; 1991 Aug; 18(2):190-7. PubMed ID: 1717778
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ATP sensitive potassium channel openers: A new class of ocular hypotensive agents.
    Roy Chowdhury U; Dosa PI; Fautsch MP
    Exp Eye Res; 2017 May; 158():85-93. PubMed ID: 27130546
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical studies with the potassium channel activator cromakalim in normotensive and hypertensive subjects.
    Donnelly R; Elliott HL; Meredith PA; Reid JL
    J Cardiovasc Pharmacol; 1990 Nov; 16(5):790-5. PubMed ID: 1703602
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiovascular effects of cromakalim (BRL 34915) in healthy volunteers.
    Fox JS; Whitehead EM; Shanks RG
    Br J Clin Pharmacol; 1991 Jul; 32(1):45-9. PubMed ID: 1888641
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacological Profile and Ocular Hypotensive Effects of Cromakalim Prodrug 1, a Novel ATP-Sensitive Potassium Channel Opener, in Normotensive Dogs and Nonhuman Primates.
    Roy Chowdhury U; Kudgus RA; Holman BH; Rinkoski TA; Hann CR; Bahler CK; McCloud E; Appt SE; Reid JM; Dosa PI; Fautsch MP
    J Ocul Pharmacol Ther; 2021 Jun; 37(5):251-260. PubMed ID: 33784195
    [No Abstract]   [Full Text] [Related]  

  • 46. Effect of short-term administration of cromakalim on renal hemodynamics and eicosanoid excretion in essential hypertension.
    Lebel M; Grose JH; Lacourcière Y
    Am J Hypertens; 1991 Sep; 4(9):740-4. PubMed ID: 1834087
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of potassium channel openers in acute and chronic models of glaucoma.
    Panchal SS; Mehta AA; Santani DD
    Taiwan J Ophthalmol; 2016; 6(3):131-135. PubMed ID: 29018728
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Topical ocular hypotensive activity and ocular penetration of dichlorphenamide sodium in rabbits.
    Lotti VJ; Schmitt CJ; Gautheron PD
    Graefes Arch Clin Exp Ophthalmol; 1984; 222(1):13-9. PubMed ID: 6510719
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of 2-alkynyladenosine derivatives on intraocular pressure in rabbits.
    Konno T; Ohnuma SY; Uemoto K; Uchibori T; Nagai A; Kogi K; Endo K; Hosokawa T; Nakahata N
    Eur J Pharmacol; 2004 Feb; 486(3):307-16. PubMed ID: 14985053
    [TBL] [Abstract][Full Text] [Related]  

  • 50. EFFECT OF HYDROGEN SULPHIDE DONOR ON INTRAOCULAR PRESSURE IN RATS.
    Mikheytseva LN; Siroshtanenko TI
    Fiziol Zh (1994); 2016; 62(5):57-61. PubMed ID: 30204343
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of four potassium channel agonists on bupivacaine-induced toxicity in mice.
    Gantenbein M; Attolini L; Bruguerolle B
    Life Sci; 1995; 57(10):PL113-6. PubMed ID: 7643714
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potassium channel stimulation in normal subjects and in patients with essential hypertension: an acute study with cromakalim (BRL 34915).
    Singer DR; Markandu ND; Miller MA; Sugden AL; MacGregor GA
    J Hypertens Suppl; 1989 Dec; 7(6):S294-5. PubMed ID: 2698941
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ocular pigmentation and intraocular pressure response to forskolin.
    Shibata T; Mishima H; Kurokawa T
    Curr Eye Res; 1988 Jul; 7(7):667-74. PubMed ID: 3416620
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The haemodynamic profile of cromakalim in the cat.
    Clapham JC; Buckingham RE
    J Cardiovasc Pharmacol; 1988; 12(5):555-61. PubMed ID: 2468055
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A submicron emulsion as ocular vehicle for delta-8-tetrahydrocannabinol: effect on intraocular pressure in rabbits.
    Muchtar S; Almog S; Torracca MT; Saettone MF; Benita S
    Ophthalmic Res; 1992; 24(3):142-9. PubMed ID: 1328979
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ATP-sensitive potassium (KATP) channel openers diazoxide and nicorandil lower intraocular pressure by activating the Erk1/2 signaling pathway.
    Roy Chowdhury U; Bahler CK; Holman BH; Fautsch MP
    PLoS One; 2017; 12(6):e0179345. PubMed ID: 28594895
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The experimental studies of the effect of Forskolin on the lowering of intraocular pressure].
    Peng T; Chen X; Zhou W; Zeng S; Shen B; Wen L; Hu B; Liu C; Yao W
    Yan Ke Xue Bao; 1992 Dec; 8(4):152-5. PubMed ID: 1306493
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and antihypertensive activity of pyran oxygen and amide nitrogen replacement analogues of the potassium channel activator cromakalim.
    Ashwood VA; Cassidy F; Evans JM; Gagliardi S; Stemp G
    J Med Chem; 1991 Nov; 34(11):3261-7. PubMed ID: 1659637
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative effects of alpha-2 and DA-2 agonists on intraocular pressure in pigmented and nonpigmented rabbits.
    Ogidigben MJ; Potter DE
    J Ocul Pharmacol; 1993; 9(3):187-99. PubMed ID: 7901309
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of topical diltiazem on ocular hypertension induced by water loading in rabbits.
    Santafé J; Martínez de Ibarreta MJ; Segarra J; Melena J
    Gen Pharmacol; 1999 Feb; 32(2):201-5. PubMed ID: 10188620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.